IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 3 49-3, 2004, Pages

  Kuemmerle, John F ^a   Zhou, Huiping ^a   Bowers, Jennifer G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclin D; Cyclin dependent kinase; Extracellular signal regulated kinase 1 2; Phosphatidylinositol 3 kinase; Retinoblastoma

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; P34PSK J3 KINASE; P34PSK-J3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RETINOBLASTOMA PROTEIN; SERINE; SOMATOMEDIN C; THYMIDINE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE G1 PHASE; CELL DIVISION; CELL GROWTH; CELL LABELING; CELL LEVEL; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; DNA MICROARRAY; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE IDENTIFICATION; GENETICS; GROWTH REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE; INTESTINE MUSCLE; JEJUNUM; METABOLISM; MUSCLE FIBER CULTURE; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; STIMULATION; TECHNIQUE; WESTERN BLOTTING;

EID: 1342344127     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00403.2003     Document Type: Article

References (40)

1. Adesanya OO, Zhou J, Samathanam C, Powell-Braxton L, and Bondy CA. Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle. Proc Natl Acad Sci USA 96: 3287-3291, 1999.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494, 1995.
3. Burroughs KD, Howe SR, Okubo Y, Fuchs-Young R, LeRoith D, and Walker CL. Dysregulation of IGF-I signaling in uterine leiomyoma. J Endocrinol 172: 83-93, 2002.
4. Bushman TL and Kuemmerle JF. IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-β1. Am J Physiol Gastrointest Liver Physiol 275: G1282-G1290, 1998.
5. 1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. J Biol Chem 275: 35942-35952, 2000.
6. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, and Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272: 6653-6662, 1997.
7. Coqueret O. Linking cyclins to transcriptional control. Gene 299: 35-55, 2002.
8. Duan C, Liimatta MB, and Bottum OL. Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway. J Biol Chem 274: 37147-37153, 1999.
9. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262, 1998.
10. 1 cyclin-dependent kinase complexes in vivo. Mol Cell Biol 21: 4773-4784. 2001.
11. Fried J, Perez AG, and Clarkson BD. Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis. J Histochem Cytochem 26: 921-933, 1978.
12. Grana X and Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219, 1995.
13. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev 8: 28-35, 1998.
14. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, and Thomas G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J 16: 3693-3704, 1997.
15. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, and Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 15: 7060-7069, 1996.
16. Kuemmerle JF. Autocrine regulation of growth in cultured human intestinal muscle by growth factors. Gastroenterology 113: 817-824, 1997.
17. Kuemmerle JF. IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase. Am J Physiol Gastrointest Liver Physiol 284: G411-G422, 2003.
18. Kuemmerle JF and Bushman TL. IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways. Am J Physiol Gastrointest Liver Physiol 275: G151-G158, 1998.
19. Kuemmerle JF and Murthy KS. Coupling of the insulin-like growth factor-I receptor tyrosine kinase to Gi2 in human intestinal smooth muscle. Gβγ-dependent mitogen-activated protein kinase activation and growth. J Biol Chem 276: 7187-7194, 2001.
20. Kuemmerle JF and Zhou H. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and ERK1/2 pathways. J Biol Chem 277: 20563-20571, 2002.
21. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, and Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 235: 1394-1399, 1987.
22. Li Y, Graham C, Lacy S, Duncan AM, and Whyte P. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7: 2366-2377, 1993.
23. Mayol X, Grana X, Baldi A, Sang N, Hu Q, and Giordano A. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8: 2561-2566, 1993.
24. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, and Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512-515, 1991.
25. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, and Rosen N. Cyclin D expression is controlled posttranscriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 273: 29864-29872, 1998.
26. Nichols TC, du Laney T, Zheng B, Bellinger DA, Nickols GA, Engleman W, and Clemmons DR. Reduction in atherosclerotic lesion size in pigs by αVβ3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling. Circ Res 85: 1040-1045, 1999.
27. Ohneda K, Ulshen MH, Fuller CR, D'Ercole AJ, and Lund PK. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 112: 444-454, 1997.
28. Phelps DE and Xiong Y. Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6. Methods Enzymol 283: 194-205, 1997.
29. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 308: 697-711, 1995.
30. Reiss K, Cheng W, Pierzchalski P, Kodali S, Li B, Wang S, Liu Y, and Anversa P. Insulin-like growth factor-1 receptor and its ligand regulate the reentry of adult ventricular myocytes into the cell cycle. Exp Cell Res 235: 198-209, 1997.
31. 1 phase integrators of the mitogenic response. Cold Spring Harb Symp Quant Biol 59: 11-19, 1994.
32. Slansky JE and Farnham PJ. Introduction to the E2F family: protein structure and gene regulation. Curr Top Microbiol Immunol 208: 1-30, 1996.
33. Stanelle J, Stiewe T, Theseling CC, Peter M, and Putzer BM. Gene expression changes in response to E2F1 activation. Nucleic Acids Res 30: 1859-1867, 2002.
34. Takahashi Y, Rayman JB, and Dynlacht BD. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816, 2000.
35. Teng B, Murthy KS, Kuemmerle JF, Grider JR, Sase K, Michel T, and Makhlouf GM. Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 275: G342-G351, 1998.
36. Vlahos CJ, Matter WF, Hui KY, and Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248, 1994.
37. Wang J, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, LeRoith D, Strauch A, and Fagin JA. Targeted overexpression of IGF-1 evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest 100: 1425-1439, 1997.
38. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenherg ME, Orkin S, Nevins JR, Robinson ML, and Leone G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414: 457-462, 2001.
39. 1/S cyclin-dependent kinases. J Biol Chem 272: 12738-12746, 1997.
40. Zimmermann EM, Li L, Hou YT, Mohapatra NK, and Pucilowska JB. Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 280: G1022-G1029, 2001.